Page 7 - Maureen Mcenroe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering July 19, 2021 18:39 ET | Source: HCW Biologics, Inc HCW Biologics, Inc Miramar, Florida, UNITED STATES MIRAMAR, Fla., July 19, 2021 (GLOBE NEWSWIRE) HCW Biologics Inc. (NASDAQ:HCWB) (the Company ), an innovative preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today announced the pricing of an underwritten initial public offering of 7,000,000 shares of common stock at a public offering price of $8.00 per share for gross proceeds of approximately $56.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. All of the shares of common stock are being offered by the Company. The shares are expected to begin trading on the Nasdaq Global Market on Jul

New yorkUnited statesMaureen mcenroeRebecca byamTiberend strategic advisors incExchange commissionBiologics incRevere securitiesCompany contactSyndicate departmentNasdaq global marketBenchmark investmentsStrategic advisorsபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்மவ்ரீன் அம்கெந்ரொ